Advanced Filters
noise

Carcinoma Clinical Trials

A listing of Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 6,091 clinical trials

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.

18 years of age All Phase N/A
T Tao Tao, MD Ph.D

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

The purpose of this prospective, single-center, single-arm trial was to evaluate the pathologic type of re-treatment based on a clear PI-RADS score of ≥4 with a first negative prostate biopsy, belonging to the high-risk group of the USTC diagnostic model, and PSMA PET/CT positive patients, and to evaluate the diagnostic …

- 75 years of age Male Phase N/A
Y Yu-Dong Zhang, MD;PHD

High Resolution Diffusion Weighted Imaging in Prostate

hrDWI might be an alternative to cDWI for the prostate imaging. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general improve the diagnostic accuracy of PCa in particular than conventional DWI

55 years of age Male Phase N/A
N Naik Vietti Violi, MD

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients …

18 years of age Male Phase N/A
R Rishma Bhatti

In Vivo Dosimetry for Brachytherapy Study

The main study aim is the investigate the clinical use of in vivo dosimeters (small measurement devices) for brachytherapy (internal radiotherapy).

18 years of age All Phase N/A
J James Wu

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood …

18 years of age All Phase N/A

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

A multicentre observational study on treatment approaches and biomarkers in de novo metastatic hormone sensitive prostate cancer in Russian Federation

18 years of age Male Phase N/A

Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens

Human papillomavirus (HPV) infection has been implicated as a necessary cause for the development of the majority of anogenital neoplasms which represent approximately 95% of anal tumors. Persistent high risk HR-HPV infection promotes progression from intraepithelial lesions high-grade squamous anal tumors (AIN) (H-SIL) to invasive anal tumors. The diagnosis of …

18 years of age All Phase N/A
A Anne E Kiltie, Prof

Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate Cancer

The digestive tract (large intestine) contains microorganisms that digest complex carbohydrates in food to produce chemical substances which are beneficial to human health. The population of these microorganisms in faeces (stool samples) could be used to diagnose the health status of a person and this can be changed with the …

60 years of age Male Phase N/A
E Eduards Mamlins, Medical Doctor

Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer

The introduction of PSMA diagnostics and therapy has fundamentally changed the treatment management of prostate cancer and has significantly replaced other clinical and radiological diagnostic methods. As a result, 18F-PSMA-1007 (Radelumin®) was approved in Germany and several EU countries, most recently in Germany in 01/2024, for use in primary staging …

18 years of age Male Phase N/A

Simplify language using AI